Simvastatin improves olanzapine-induced dyslipidemia in rats through inhibiting hepatic mTOR signaling pathway

Xuemei Liu(Chongqing Medical and Pharmaceutical College), Changhua Hu(Southwest University)
Acta Pharmacologica Sinica
February 6, 2019
Cited by 29


Related Papers